Experienced in Postpartum Depression

Michael A. Schumacher

UMR1195, 80, Rue Du Général Leclerc, 
Rouez, FR 
Experienced in Postpartum Depression
UMR1195, 80, Rue Du Général Leclerc, 
Rouez, FR 
OverviewLocationsClinical Research

Overview

Michael Schumacher practices in Rouez, France. Schumacher is rated as an Experienced expert by MediFind in the treatment of Postpartum Depression. Their top areas of expertise are Helicobacter Pylori Infection, Facial Paralysis, Gastritis, Oophorectomy, and Orchiectomy.

Their clinical research consists of co-authoring 149 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Postpartum Depression.

Locations

UMR1195, 80, Rue Du Général Leclerc, Rouez, 94276, France
Other Locations
Paris, France
UMR1195, 80, Rue Du General Leclerc, Orsay, 94276, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug, Device
Study Drug: Immune checkpoint inhibitors or docetaxel
Study Phase: Phase 3
A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

148 Total Publications

Probiotic-mediated regulation of arginine metabolism to improve intestinal barrier function: a metabolic makeover for IBD?
Probiotic-mediated regulation of arginine metabolism to improve intestinal barrier function: a metabolic makeover for IBD?
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Schumacher's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile